首页 正文

Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?

{{output}}
Gene-expression profiling and next-generation sequencing have defined diffuse large B-cell lymphoma (DLBCL), the most common lymphoma diagnosis, as a heterogeneous group of subentities. Despite ongoing explosions of data illuminating disparate pathogenic mecha... ...